A randomized controlled trial evaluating the effects of hormone replacement therapy on bone mineral density and disease course in postmenopausal women with rheumatoid arthritis.

Trial Profile

A randomized controlled trial evaluating the effects of hormone replacement therapy on bone mineral density and disease course in postmenopausal women with rheumatoid arthritis.

Completed
Phase of Trial: Phase II

Latest Information Update: 03 Nov 2010

At a glance

  • Drugs Estradiol (Primary) ; Ethinylestradiol/norethisterone
  • Indications Menopause; Rheumatoid arthritis
  • Focus Pharmacodynamics
  • Most Recent Events

    • 01 Jul 2009 Planned number of patients (88), actual initiation date (Apr 2004) and actual end date (31 Dec 2005) added as reported by ISRCTN: Current Controlled Trials.
    • 01 Jul 2009 Additional lead trial centres identified as reported by ISRCTN: Current Controlled Trials.
    • 01 Jul 2009 Status changed from not stated to completed as reported by ISRCTN: Current Controlled Trials.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top